“…Notably, mutant mouse models have been generated for all SLC26 members, and all reproduced the clinical features of the SLC26 human-related diseases when applicable (Liberman et al, 2002; Forlino et al, 2005; Schweinfest et al, 2006; Touré et al, 2007; Dallos et al, 2008; Dror et al, 2010; El Khouri et al, 2018). In addition, studies of members not so far associated with human diseases (SLC26A7 and A11) revealed their functions in various tissues such as kidney, gastro intestinal tract, enamel, vestibular membrane of the cochlea, and brain (Xu et al, 2009; Rahmati et al, 2013, 2016; Kim et al, 2014; Yin et al, 2017), predicting that further investigations might lead to the identification of novel SLC26 gene mutations associated with pathophysiological conditions in humans (Table 1). Lastly SLC26 function may be critical for cystic fibrosis condition (CF; MIM 219700), a disease which is due to mutations in CFTR, and characterized by general defective electrolyte transport, chronic lung infections and inflammation, respiratory failure, digestive symptoms and male infertility (i.e., congenital bilateral absence of the vas deferens).…”